|
CCT6A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.069600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.811630E-02 |
| Normal-vs-Stage2 |
1.869360E-01 |
| Normal-vs-Stage3 |
3.942500E-02 |
| Normal-vs-Stage4 |
4.521800E-01 |
| Stage1-vs-Stage2 |
9.846600E-01 |
| Stage1-vs-Stage3 |
6.536200E-01 |
| Stage1-vs-Stage4 |
5.080400E-02 |
| Stage2-vs-Stage3 |
7.800600E-01 |
| Stage2-vs-Stage4 |
1.161620E-01 |
| Stage3-vs-Stage4 |
4.467700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.589700E-02 |
| Normal-vs-AfricanAmerican |
5.916400E-02 |
| Normal-vs-Asian |
5.645000E-01 |
| Caucasian-vs-AfricanAmerican |
5.607800E-01 |
| Caucasian-vs-Asian |
1.855200E-01 |
| AfricanAmerican-vs-Asian |
3.314800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.500400E-02 |
| Normal-vs-Female |
1.590950E-01 |
| Male-vs-Female |
7.825400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.400200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.874300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.362600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.053700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.975200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.850600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.775400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.972600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.848220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.969700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.428200E-01 |
| Normal-vs-Grade 2 |
8.066400E-02 |
| Normal-vs-Grade 3 |
3.583800E-02 |
| Normal-vs-Grade 4 |
6.731000E-01 |
| Grade 1-vs-Grade 2 |
6.274400E-01 |
| Grade 1-vs-Grade 3 |
7.690400E-01 |
| Grade 1-vs-Grade 4 |
5.876400E-01 |
| Grade 2-vs-Grade 3 |
6.370600E-01 |
| Grade 2-vs-Grade 4 |
6.240800E-01 |
| Grade 3-vs-Grade 4 |
4.612000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.568200E-02 |
| Normal-vs-ccB subtype |
3.069600E-01 |
| ccA subtype-vs-ccB subtype |
5.791400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.896200E-01 |
| Normal-vs-N1 |
5.610400E-01 |
| N0-vs-N1 |
4.227800E-01 |
|
|
